U.S. Handheld Echocardiography Devices Market
The U.S. Handheld Echocardiography Devices Market is witnessing steady expansion as portable cardiac imaging technology becomes increasingly integrated into modern healthcare delivery. Handheld echocardiography devices allow clinicians to connect an ultrasound probe directly to a mobile phone or tablet, enabling rapid visualization of cardiac images at the point of care. This shift away from bulky, cart-based systems toward compact, user-friendly alternatives is transforming how cardiovascular assessments are performed across hospitals, diagnostic centers, and emergency care settings in the United States.
Market Size and Growth Trajectory
According to Fortune Business Insight, the U.S. handheld echocardiography devices market was valued at USD 21.6 million in 2022 and is estimated to have grown to USD 23.9 million in 2023. The market is further projected to reach USD 52.6 million by 2030, reflecting a compound annual growth rate (CAGR) of 11.9% during the 2023–2030 forecast period. This growth trend underscores the increasing reliance on portable diagnostic tools as healthcare providers seek faster, more convenient methods of detecting cardiac abnormalities without compromising diagnostic quality.
Understanding the Technology
Echocardiography remains one of the most widely used non-invasive diagnostic procedures for identifying heart conditions such as chest pain and valve stenosis. While cart-based and portable systems have long been standard in hospitals and radiology centers, handheld devices offer a distinct advantage in portability and ease of use. Clinicians can carry these compact devices directly to a patient's bedside, in an ambulance, or into an emergency room, allowing for immediate assessment without the delays associated with scheduling a formal echocardiogram in a dedicated imaging suite.
Key Drivers Fueling Market Growth
Rising Prevalence of Cardiovascular Disease
One of the most significant factors propelling this market is the growing burden of heart disease across the country. According to Fortune Business Insight, data published by the CDC in 2022 indicated that approximately 805,000 people in the U.S. experience a heart attack every year. This high incidence has heightened public awareness around the importance of routine screening and early diagnosis, encouraging both patients and providers to seek accessible, rapid diagnostic solutions. Additionally, according to Fortune Business Insight, around 47.0% of Americans carry at least one of three major risk factors for heart disease, namely high blood pressure, high cholesterol, or smoking, further amplifying the need for widespread screening tools.
Expanding Use in Emergency Care
Handheld echocardiography devices have found particular value in emergency departments, where speed and portability are critical. According to Fortune Business Insight, CDC data shows that there were 131 million emergency department visits in the U.S. in 2020 alone. This volume of patient traffic has created substantial demand for diagnostic tools that can deliver quick, on-the-spot cardiac assessments, reinforcing the role of handheld devices in acute care environments. Beyond emergency use, these devices are also employed to monitor patients undergoing cancer treatments that carry a risk of cardiotoxicity, broadening their clinical applications.
Growing Adoption of Point-of-Care Ultrasound Training
Educational initiatives are also playing a role in market expansion. According to Fortune Business Insight, data published by BioMed Central Ltd in 2021 revealed that around 60.0% of U.S. medical schools had incorporated Point-of-Care Ultrasound (POCUS) training into their curricula by 2014, with adoption continuing to rise in subsequent years. As more clinicians and nursing staff receive formal training on handheld ultrasound technology, the pool of qualified users capable of operating these devices continues to grow, supporting broader market penetration.
Integration of Artificial Intelligence
A notable trend shaping the market is the increasing incorporation of artificial intelligence into handheld echocardiography systems. AI-driven software solutions are being developed to guide less experienced users through the scanning process, addressing the shortage of skilled technicians capable of operating these devices. AI tools are also being used to help interpret images across multiple modes, including 2D ultrasound and color Doppler, assisting in the detection of conditions such as valvular heart disease, cardiomyopathy, and coronary atherosclerotic heart disease.
Market Segmentation
The market is segmented by test type, technology, and end-user. By test type, transthoracic echocardiography held a dominant share in 2022, driven largely by its effectiveness in detecting coronary artery disease. According to Fortune Business Insight, CDC data from 2020 showed that approximately 20.1 million adults aged 20 and older had coronary artery disease, while about 697,000 people died from heart disease that year, reinforcing demand for this test type.
By technology, the market is divided into 2D and Doppler imaging, with the 2D segment capturing a significant share due to continuous product innovation. Doppler imaging, meanwhile, is expected to grow at a notable pace owing to its superior imaging quality and accuracy compared to standard 2D imaging.
By end-user, hospitals and ambulatory surgical centers (ASCs) led the market in 2022. According to Fortune Business Insight, American Hospital Association data from November 2021 indicated that most of the 6,090 hospitals in the U.S. maintained intensive care units, many of which are increasingly equipped with handheld diagnostic tools to support advanced cardiac care.
Challenges Facing the Market
Despite strong growth prospects, handheld echocardiography devices face certain limitations. Current models, including widely used devices, generally lack advanced 3D and 4D imaging capabilities, offering only 2D and Doppler functionality. This restricts their use largely to screening purposes, often requiring confirmation through conventional echocardiography for a definitive diagnosis. Image resolution constraints also remain a barrier to broader clinical adoption in cases requiring more detailed cardiac visualization.
Competitive Landscape
The market features several established players focused on technological innovation, including global healthcare technology companies that continue to introduce advanced handheld ultrasound systems with expanded imaging capabilities, improved hemodynamic assessment features, and enhanced portability. Strategic partnerships between device manufacturers and AI solution providers have also become increasingly common, aimed at improving the accuracy and ease of use of handheld cardiac imaging tools.
Conclusion
The U.S. handheld echocardiography devices market is positioned for meaningful growth through 2030, supported by rising cardiovascular disease prevalence, expanding emergency care applications, growing clinician training initiatives, and the integration of artificial intelligence into diagnostic workflows. While technical limitations around imaging depth and resolution persist, ongoing innovation from key industry players is expected to gradually address these gaps, further strengthening the role of handheld devices in routine and emergency cardiac care across the country.
Source:https://www.fortunebusinessinsights.com/u-s-handheld-echocardiography-devices-market-107758